These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26900329)

  • 1. How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project.
    Gasparini R; Mennini FS; Panatto D; Bonanni P; Bechini A; Ricciardi W; DE Waure C; Marcellusi A; Cicchetti A; Ruggeri M; Boccalini S
    J Prev Med Hyg; 2015; 56(4):E150-4. PubMed ID: 26900329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The economic value of vaccinations: a systematic review of Italian economic evaluations and HTA reports].
    Di Nardo F; Boccalini S; Calabrò GE; Marcellusi A; Ruggeri M; Bonanni P; Vitali R; Capannini E; Mennini FS; Cicchetti A; Panatto D; Gasparini R; Ricciardi W; De Waure C
    Ig Sanita Pubbl; 2017; 73(5):453-471. PubMed ID: 29433132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community views and perspectives on public engagement in health technology assessment decision making.
    Wortley S; Tong A; Howard K
    Aust Health Rev; 2017 Mar; 41(1):68-74. PubMed ID: 27050156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public preferences for engagement in Health Technology Assessment decision-making: protocol of a mixed methods study.
    Wortley S; Tong A; Lancsar E; Salkeld G; Howard K
    BMC Med Inform Decis Mak; 2015 Jul; 15():52. PubMed ID: 26166149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.
    Feig C; Cheung KL; Hiligsmann M; Evers SMAA; Simon J; Mayer S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):223-232. PubMed ID: 28862060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary.
    Kaló Z; Bodrogi J; Boncz I; Dózsa C; Jóna G; Kövi R; Pásztélyi Z; Sinkovits B;
    Value Health Reg Issues; 2013; 2(2):264-266. PubMed ID: 29702875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HTA Core Model
    Kristensen FB; Lampe K; Wild C; Cerbo M; Goettsch W; Becla L
    Value Health; 2017 Feb; 20(2):244-250. PubMed ID: 28237203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A determination of topics for health technology assessment in Thailand: making decision makers involved.
    Lertpitakpong C; Chaikledkaew U; Thavorncharoensap M; Tantivess S; Praditsitthikorn N; Youngkong S; Yothasamut J; Udomsuk K; Sinthitichai K; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S100-9. PubMed ID: 19253492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methodological aspects of clinical and economic impact of vaccine interventions and HTA. Focus on HPV vaccination].
    Ricciardi W; Dirodi B; Bonanni P; Capri S; Castiglia P; Gabutti G; Gasparini R; Giorgi Rossi P; Grilli G; La Torre G
    Ann Ig; 2011; 23(5):419-34. PubMed ID: 22403995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of health technology assessment in coverage decisions on newborn screening.
    Fischer KE; Grosse SD; Rogowski WH
    Int J Technol Assess Health Care; 2011 Oct; 27(4):313-21. PubMed ID: 22004771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance for future HTA applications to vaccines: the HPV lesson.
    La Torre G; de Waure C; Chiaradia G; Mannocci A; Capri S; Bamfi F; Ricciardi W
    Hum Vaccin; 2011 Sep; 7(9):900-4. PubMed ID: 21865880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supporting decision making in cross-border regions: a health technology assessment tool for hospitals.
    Knies S; Lombardi G; Commers M; Dauben HP; Evers S; Michelsen K; Oortwijn W; Opara C; Brand H
    Int J Technol Assess Health Care; 2013 Jan; 29(1):71-8. PubMed ID: 23253106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.
    Frønsdal KB; Facey K; Klemp M; Norderhaug IN; Mørland B; Røttingen JA
    Int J Technol Assess Health Care; 2010 Jul; 26(3):309-16. PubMed ID: 20584360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the scope of health technology assessment and types of health economic evaluation.
    Tanvejsilp P; Ngorsuraches S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S10-6. PubMed ID: 24964694
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.